Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Walgreen Company : Walgreen April Same-Store Sales Fall Bigger-Than-Expected 6.4%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 02:39pm CEST

Walgreen Co.'s (WAG) April same-store sales fell a bigger-than-expected 6.4%--marking the fourth straight month of declines--as the drug-store chain's loss of Express Scripts Holding Co.'s (ESRX) members continued to hamper results.

Analysts polled by Thomson Reuters expected April same-store sales to fall 5.1%.

A conflict between Walgreen and Express Scripts over new contract terms erupted publicly last June, and Walgreen said it wouldn't be part of the pharmacy-benefits manager's network when their deal expired in 2011. The benefit manager's clients now have to go elsewhere to fill prescriptions.

Total sales fell 3.7% to $5.78 billion last month.

April same-pharmacy sales decreased 8.9% and missed the analysts' projected 8.6% decline.

Total pharmacy sales fell 6.3%. Prescriptions filled at same-stores declined 7.8% in April, reflecting the loss of Express Scripts members, a lower incidence of flu and more generic drug introductions. Prescriptions processed by Express Scripts comprised 12.6% of Walgreen's prescriptions a year earlier.

In the front of the store, same-store sales slipped fell 2.2% last month, compared with the analysts' flat front-end same-store sales forecast.

Total front-end sales slipped 0.5%. Customer traffic at same-stores fell 3% and average basket size increased 0.8%.

Walgreen reported in March its fiscal second-quarter earnings fell 7.7% as its exit from Express Scripts's network and a mild cold and flu season offset a 0.8% pop in total sales.

Shares closed Wednesday at $34.15 and were inactive premarket. The stock has gained 3.3% since the beginning of the year.

-By Melodie Warner, Dow Jones Newswires; 212-416-2283; [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
05/24 WALGREENS : Honors Veterans, Active Duty Military and Families with Memorial Day..
05/24 Fred's Pharmacy Declares Quarterly Cash Dividend of $0.06 Per Share
05/23 WALGREENS BOOTS ALLIANCE : Major firms commit to hiring more older workers by 20..
05/23 WALGREENS : Mental Health Platform Helping to Reach Broader Demographic and Expa..
05/18 WALGREENS BOOTS ALLIANCE : to Present Research from Five Clinical Studies at Int..
05/16 WALGREENS BOOTS ALLIANCE : to Participate at UBS Global Healthcare Conference
05/16 WALGREENS BOOTS ALLIANCE INC : ex-dividend day
05/10 WALGREENS BOOTS ALLIANCE : VA, VFW and Walgreens Collaborate to Enhance Veterans..
05/09 RITE AID CORPORATION (NYSE : RAD) Files An 8-K Other Events
05/09 Walgreens moves to force U.S. decision on Rite Aid merger
More news
Sector news : Drug Retailers - NEC
05/17DJCVS HEALTH : Why Your Pharmacy May Be Texting You -- WSJ
05/15 SHANGHAI PHARMACEUTICALS : Advent, Shanghai Pharma have not approached Stada - s..
05/02 CVS HEALTH : profit beats as pharmacy margins rise
05/02DJCVS HEALTH : Profit Declines in First Quarter of 'Rebuilding Year'
04/26DJANTHEM : Says ACA Payment Loss Could Cause 20% Premium Hike -- Update
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2017 117 610 M
EBIT 2017 7 348 M
Net income 2017 4 598 M
Debt 2017 10 782 M
Yield 2017 1,88%
P/E ratio 2017 19,12
P/E ratio 2018 16,45
EV / Sales 2017 0,83x
EV / Sales 2018 0,77x
Capitalization 87 287 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 93,5 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%87 287
WALGREENS BOOTS ALLIAN..-2.43%87 287
CVS HEALTH CORP-3.75%77 378
EXPRESS SCRIPTS HOLDIN..-12.98%36 073
MCKESSON CORPORATION14.80%34 242
CARDINAL HEALTH INC1.57%23 198
More Results